Well said, further to that from Synlait last half yearly, 12 months ago which clearly shows they had done the ground work to get the ball rolling, delays by the regulator due to covid restrictions etc are well outside company control;
The a2 Milk Company • Renewing the State Administration for Market Regulation (SAMR) licence for Chinese labelled a2 Platinum® Infant Formula is a critical project: • Dossier submitted to SAMR and technical review expected to be complete by end of April. • Onsite audit to be conducted by Ministry for Primary Industries (MPI) on behalf of SAMR likely in June/July. • Re-registration decision expected by end of 2022.
A2M Price at posting:
$5.97 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)